Editorial: Serendipity-methotrexate and 6-mercaptopurine for continuation therapy for patients with acute lymphoblastic leukemia: The leukemic stem cell and beyond?

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 6, 2009, Pages 383-384

  Kamen, Barton A ^a,b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b The Leukemia & Lymphoma Society   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTOPURINE; METHOTREXATE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER COMBINATION CHEMOTHERAPY; CHILD CARE; CLINICAL TRIAL; CYTOTOXICITY; DNA REPAIR; DRUG POTENCY; DRUG TARGETING; EDITORIAL; HUMAN; LEUKEMIA CELL; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; NOTE;

6-MERCAPTOPURINE; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; METHOTREXATE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 67651211187     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181a6e191     Document Type: Editorial

References (14)

1. Definition of serendipity from Wikipedia (the free encyclopedia).
2. Schmiegelow K, Heyman M, Kristinsson J, et al. Oral methotrexate/6- mercaptopurine may be superior to a multi-drug LSA2L2 maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
3. Cox CV, Diamanti P, Evely RS, et al. Expression of CD133 on leukemia initiating cells in childhood ALL. Blood [Epub ahead of print].
4. Cheok MH, Evans WE. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy. Nat Rev Cancer. 2006;6:117-129.
5. Yang JJ, Cheng C, Yang W, et al. Genome-wide interrogation of germ line genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA. 2009;301: 393-403.
6. Grant P. The influence of folic acid analogs on development and nucleic acid metabolism in Rana pipiens embryos. Dev Biol. 1960;2:197-251.
7. Stearns LW, Martin WE, Jolley WB, et al. Effects of certain pyrimidines on cleavage and nucleic acid metabolism in sea urchin, Strongylocentrotus purpuratus, embryos. Exp Cell Res. 1962;27:250-259.
8. Mathews CK. Giant pools of DNA precursors in sea urchin eggs. Exp Cell Res. 1975;92:47-56.
9. Conter V, Valsecchi MG, Silvestri D, et al. Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial. Lancet. 2007;369:123-131.
10. Vormoor HJ. Malignant stem cells in childhood acute lymphoblastic leukemia: the stem cell concept revisited. Cell Cycle. 2009;8:1-4.
11. Morisot S, Wayne AS, Bohana-Kashtan O, et al. Leukemia stem cells (LSCs) are frequent in childhood precursor B acute lymphoblastic leukemia (ALL) [Abstract No. 1354]. Blood. 2008;112:487.
12. Brodsky G, Barnes T, Bleskan J, et al. The human GARS-AIRS- GART gene encodes two proteins which are differentially expressed during human brain development and temporally overexpressed in cerebellum of individuals with Down syndrome. Hum Mol Genet. 1997;6:2043-2050.
13. Frost P, Kamen BA. The bullseye of cancer therapy: a moving target. Curr Opin Pharmacol. 2003;3:335-337.
14. Weitman SD, Kamen BA. Combination chemotherapy: a case of new math? When an addition is a subtraction. Cancer Res Ther Control. 1994;4:1-2.